Skip to main content
. 2017 Nov 24;15(2):1580–1590. doi: 10.3892/ol.2017.7484

Figure 3.

Figure 3.

(A) Percentage of CLL iNKT cells (among CD3+ T lymphocytes) in patients with CLL and in HVs. (B) Percentage of CLL iNKT cells with IL-4 or IFN-γ expression in patients with CLL and in HVs. (C) Dot plots depict iNKT cells with high and low expression of IL-4 for two patients with CLL (CLL1, CLL2) and two HVs (HV1, HV2). (D) Dot plots depict iNKT cells with high and low expression of IFN-γ for two patients with CLL (CLL1, CLL2) and two HVs (HV1, HV2). CLL, chronic lymphocytic leukemia; iNKT, invariant natural killer T cells; IL, interleukin; IFN, interferon; HV, healthy volunteer.